Research Paper Volume 15, Issue 17 pp 8851—8872
Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
Figure 2. Correlations between AKAP8L expression and molecular subtypes across TCGA tumors. (A) UCEC; (B) BRCA; (C) LUSC; (D) HNSC; (E) OV; (F) LGG; (G) STAD; (H) KIRP; (I) ACC; (J) COAD; (K) GBM.